Getting To $80 Bil.: PhRMA Expects Mix Of Rebates And Fees In Finance Bill
Executive Summary
The Pharmaceutical Research and Manufacturers of America is expecting to make good on its pledge to contribute $80 billion to health care reform through a combination of drug rebates and fees, in addition to savings from follow-on biologics and the previously announced 50 percent discount on drugs used in the Medicare Part D donut hole
You may also be interested in...
Schumer Wants To Up Pharma Reform Ante To $106 Bil. Via Medicare Rebates
Sen. Chuck Schumer is looking to revive the idea of getting more savings from the pharmaceutical industry than the $80 billion already pledged toward health reform and is eyeing Senate floor debate as the venue
Schumer Wants To Up Pharma Reform Ante To $106 Bil. Via Medicare Rebates
Sen. Chuck Schumer is looking to revive the idea of getting more savings from the pharmaceutical industry than the $80 billion already pledged toward health reform and is eyeing Senate floor debate as the venue
Sen. Schumer Wants Pharma's Health Reform Contribution Upped To $106 Bil. Via More Medicare Rebates
Schumer suggests pharma contribution could resurface during Senate floor debate on health reform.